← All organizations
Highest phase reached
Phase 3
First marketed drug
Jun 1, 2016Last known activity
May 1, 2016
Timeline
2010s
- May 15, 2015
Aerocrine AB— Acquired
- May 15, 2015
Prosonix Limited— Acquired
- Jun 1, 2016
Circassia Limited— Founded
- Mar 29, 2019
formoterol— NDA Secondary Org
Drugs by trial phase (13 distinct, 29 trials)
Phase 4 (0 own, 3 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (4 own, 1 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Marketed drugs (2)
Subsidiaries (2 direct, 2 total across the full acquisition tree)
Recent trials (25)
- NCT02795273Lead sponsorPhase 2/Phase 3May 1, 2016
- NCT02478060Lead sponsorPhase 2Jul 1, 2015
- NCT02311413CollaboratorPhase 2Jan 1, 2015
- NCT02150343Lead sponsorPhase 2Sep 1, 2014
- NCT02161107Lead sponsorPhase 2Apr 1, 2014
- NCT02040844Lead sponsorPhase 3Feb 28, 2014
- NCT02061709Lead sponsorPhase 2Jan 1, 2014
- NCT02061670Lead sponsorPhase 2Jan 1, 2014
- NCT01949441Lead sponsorPhase 2Sep 1, 2013
- NCT01921257Lead sponsorPhase 2Aug 1, 2013
- NCT01743118Lead sponsorPhase 1Mar 1, 2013
- NCT01620762Lead sponsorPhase 3Oct 1, 2012
- NCT01383590Lead sponsorPhase 1Oct 1, 2011
- NCT01383603Lead sponsorPhase 1Oct 1, 2011
- NCT01447784Lead sponsorPhase 2Sep 1, 2011
Details
- Founded
- Oxford, GB Jun 1, 2016
- Last known activity
- May 1, 2016